Long Term Persistence Of Sars Cov 2 clinical trials

Explore recruiting long term persistence of sars cov 2 clinical trials.

Also recruiting in Europe

Long Term Persistence Of Sars Cov 2 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Achieving viral CLEARance in immunocompromised participants with long-term persistence of SARS-CoV-2 - an open-label randomized trial (CLEAR)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Long Term Persistence Of Sars Cov 2 trials by city

Long Term Persistence Of Sars Cov 2 in Toronto Long Term Persistence Of Sars Cov 2 in Vancouver Long Term Persistence Of Sars Cov 2 in Montreal Long Term Persistence Of Sars Cov 2 in Calgary Long Term Persistence Of Sars Cov 2 in Edmonton Long Term Persistence Of Sars Cov 2 in Ottawa Long Term Persistence Of Sars Cov 2 in Winnipeg Long Term Persistence Of Sars Cov 2 in Quebec City Long Term Persistence Of Sars Cov 2 in Hamilton Long Term Persistence Of Sars Cov 2 in Kitchener Long Term Persistence Of Sars Cov 2 in London Long Term Persistence Of Sars Cov 2 in Halifax Long Term Persistence Of Sars Cov 2 in New York Long Term Persistence Of Sars Cov 2 in Los Angeles Long Term Persistence Of Sars Cov 2 in Chicago Long Term Persistence Of Sars Cov 2 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease